Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Skin Protectant Final Rule Allows Cross-Monograph Ingredient Combinations

This article was originally published in The Tan Sheet

Executive Summary

The OTC Skin Protectant Final Monograph covering products for minor cuts, scrapes, burns, chapped skin and lips, poison ivy, poison oak, poison sumac and insect bites allows for certain cross-monograph ingredient combinations, according to the rule published in the 1Federal Register June 4

You may also be interested in...



FDA Clarifies Skin Protectant Labeling, Ingredient Combination Options

FDA attempts to clarify the active ingredients manufacturers may combine in OTC skin protectant drug products and details corresponding label requirements in draft guidance released Aug. 1

FDA Clarifies Skin Protectant Labeling, Ingredient Combination Options

FDA attempts to clarify the active ingredients manufacturers may combine in OTC skin protectant drug products and details corresponding label requirements in draft guidance released Aug. 1

FDA Clarifies Skin Protectant Labeling, Ingredient Combination Options

FDA attempts to clarify the active ingredients manufacturers may combine in OTC skin protectant drug products and details corresponding label requirements in draft guidance released Aug. 1

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS095566

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel